ERNA ▲ +5.1% - Ernexa Therapeutics Inc. $ERNA - Ernexa Therapeutics Appoints Accomplished Biopharmaceutical Executive Robert J. Spiegel, M.D., FACP, to Board of Directors Ernexa Therapeutics appointed Dr. Robert J. Spiegel, an accomplished biopharmaceutical executive, to its board of directors, driving shares up 5.1% today. The appointment signals the company's confidence in bringing experienced leadership to its governance as it advances its therapeutic pipeline. 17-SEP-2026 08:42 AM ET